Copy

New opportunities in cancer and cancer health disparities research!

"The flower that blooms in adversity,
is the rarest and most beautiful of all.." -- Walt Disney

 

Good morning, GMaP Region 3...


How are you holding up in our new normal? I hope you are doing well. But I know that some people are concerned about contracting COVID-19, struggling to conduct population-based research during social distancing, homeschooling children, facing financial challenges, or just generally feeling distressed. If you are feeling some stress, and are looking for a new strategy to cope with those feelings, you might try meditation. I came across this simple, yet meaningful, 13 minute Loving Kindness Meditation put out by University of New Hampshire Health and Wellness https://www.youtube.com/watch?v=sz7cpV7ERsM&t=3s. It's a good place to start, or refresh, and I hope you find it helpful.

While we are all in quarantine, the world continues to move around us, and we are fortunate to have many new opportunities for you to check out! 
 

Professional Development Opportunities!

  • Research Associate in Global Cancer Epidemiology at Duke University Department of Population Health -- New!
  • Associate to Full Professor Cancer Epidemiology, University of Arizona, Mel & Enid Zuckerman College of Public Health, in partnership with the University of Arizona Cancer Center -- New!
  • Tenure Track Faculty Positions, Division of Epidemiology, Department of Population Health Sciences, Weill Cornell Medicine  -- New!
  • FDA U.S. Food & Drug Administration Center for Tobacco Products, Social Scientist -- New!

Research Opportunity!

  • ASPO Disparities SIG Lightning Talks Webinar - New!

Training Opportunities!

  • Pre-Application Webinar for the Basic Research in Cancer Health Disparities PARs - New!
  • SciTS 2020 - The International Science of Team Science Conference, Durham, North Carolina, June 1-4, 2020 - New!

Many New Funding Opportunities!

Professional Development ...

Research Associate in Global Cancer Epidemiology at Duke University Department of Population Health Sciences
 

The Department of Population Health Sciences at Duke University School of Medicine invites applications for a Research Associate in global cancer epidemiology. Our program utilizes theoretical frameworks and methods from social and molecular epidemiology to investigate health disparities across the cancer prevention continuum in the US and abroad. Ongoing projects involve collaborative studies to generate scientific evidence aimed at understanding and addressing the fundamental causes of cancer disparities
 
The Research Associate will work in a vibrant, team-based and diverse environment to provide scientific input for day-to-day research activities such as proposal and manuscript development, statistical analysis, project management, and engaging with other data analysts, students, post-docs and faculty on the team
 
Basic Qualifications:
Doctoral qualification in epidemiology, statistics, public health or a closely related field with 2+ years practical research experience preferred. Master’s degree with at least 3 years of research experience will also be considered. The ideal candidate will have strong background in epidemiologic methods, formal training in cancer, and a strong interest/experience in global health research.
 
Desired skills:
  • Excellent analytical, organizational and problem-solving skills
  • Experience with applied epidemiological research including ability to generate research questions, conduct data analysis and synthesize results
  • Excellent scientific writing skills
  • Expert knowledge and practical experience in study design, sampling approaches, and advanced statistical methods
  • Experience managing prospective studies and quantitative/qualitative data collection
  • Expert knowledge of statistical packages e.g. SAS, R, STATA
  • Excellent interpersonal, oral and written communication skills
 
Required Application Documents:
  • Current CV
  • Cover letter
  • Statement of research
  • Two writing samples (reflecting independent writing)
  • Names of three references
 
Interested candidates should apply at:
https://careers.duke.edu/job/Durham-ASSOCIATE-IN-RESEARCH-NC-27710/622371500/

Associate to Full Professor (T/TE) Cancer Epidemiology, University of Arizona Mel & Enid Zuckerman College of Public Health, in partnership with the University of Arizona Cancer Center in Tucson, AZ


The University of Arizona Mel & Enid Zuckerman College of Public Health in partnership with The University of Arizona Cancer Center in Tucson, Arizona is seeking a dynamic, mid or later career cancer epidemiologist to advance our nationally recognized efforts in cancer prevention and control. We are particularly interested in individuals with expertise in catchment-related cancers including breast, prostate, lung, colorectal, liver as well as head and neck cancer. We also prefer individuals with experience with large datasets, including genetic data or experience in artificial intelligence. The individual will collaborate with other epidemiologists, biostatisticians, geneticists, biologists, and clinicians at the University of Arizona as well as numerous public health partners and collaborators throughout the state of Arizona to advance programming in cancer prevention and control epidemiology. Importantly, this position will build on the health disparities efforts across the state with an emphasis on our catchment populations including Hispanic/Latinos, Native Americans, rural residents and the aging. Previous research experience, successful peer-reviewed grant funding, and a relevant publication
record are required. The candidate will be expected to have an independent research program with peer-reviewed funding and to lead efforts to build a cancer prevention and control cohort within our catchment area.
 
The successful candidate will have an opportunity to interact and collaborate with the other UA Health Sciences colleges on a shared campus that includes Public Health, Pharmacy, Medicine, and Nursing.
 
Qualifications
Minimum Required
• Doctoral degree in epidemiology or closely related field
• Recent (within the last 2 y) academic employment at the Associate Professor or Professor
ranking
• Evidence of current (or competitively scored) grant funding through NCI in
epidemiological research
• Instructional experience at the university level
Preferred
• Research expertise in environmental exposure or infectious disease
• Prior experience with large epidemiological datasets
• Prior experience with cohort development
 
Please submit a cover letter, curriculum vitae, and the names and contact information for three references to: UAHS Human Resources, 1451 North Warren Ave., P.O. Box 245010, Tucson AZ 85724-5010.
 
Review of materials will begin May 15, 2020 and will continue until position is filled.

Tenure Track Faculty Positions
Division of Epidemiology, Department of Population Health Sciences

 

The Department of Population Health Sciences is the flagship population health research department of Weill Cornell Medicine and NewYork-Presbyterian Hospital. The Division of Epidemiology seeks multiple full-time tenure-track positions at the rank of Assistant, Associate, or Full Professor. We are seeking outstanding individuals engaged in research related to cancer prevention and control, including, but not limited to, implementation science, data science, or epidemiologic methods with research in substantive areas such as breast, colorectal, lung, cervical and prostate cancer, infection related cancers, geospatial sciences, screening, health disparities, or tobacco control. Research portfolios may include a range of topics, from molecular to social determinants of cancer. Candidates should have a Ph.D. or an MD with additional graduate training (e.g. M.P.H., MS, or fellowship).


The Department of Population Health Sciences (https://hpr.weill.cornell.edu/) is home to six Divisions. The Department is multi-disciplinary with substantial research strengths across a variety of areas including health policy and economics, health data science and data analytics, health informatics, comparative effectiveness & outcomes research, healthcare delivery science, epidemiology and biostatistics. The division of Epidemiology envisions housing a multidisciplinary group of PhD and/or MD population science investigators dedicated to careers in building scientific evidence and cultivating a next-generation workforce conducting epidemiologic research.


Faculty in this division will leverage the burgeoning status of New York City as the epicenter of clinical medicine, and will be integral to the Cancer Prevention and Control Research Program within the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. As a matrixed cancer center, the Meyer Cancer Center converges the talent of basic, translational, clinical and population-based cancer investigators across Weill Cornell Medicine to take fundamental discoveries from bench to bedside to population, and back again. Additional resources include the Englander Institute for Precision Medicine, the Cornell Center for Health Equity, and NewYork-Presbyterian, the premier healthcare system in New York City including NewYork -Presbyterian Brooklyn Methodist Hospital, and NewYork-Presbyterian Queens.


Send CV and a cover letter stating specific reasons for your interest and a brief statement of career goals electronically to:
Rulla Tamimi – rmt4001@med.cornell.edu


Weill Cornell Medical College is an employer and educator recognized for valuing AA/EEO, Protected Veterans and Individuals with Disabilities.

Social Scientist: 0101- GS- 12/13, Food and Drug Administration's Center for Tobacco Products


Job Vacancy link: https://www.usajobs.gov/GetJob/ViewDetails/563339400
Open/Close Date: 3/20/2020 – 3/26/2020
Salary:  $86,335- $133,465 per year
CTP Job Link: fda.gov/ctpjobs

Summary
The Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) regulates the manufacturing, marketing, and distribution of tobacco products. Our goal is to reduce the harm from all regulated tobacco products across the entire population, including: reducing the number of people who start to use tobacco products, encouraging more people to stop using these products, and reducing the adverse health impact for those who continue to use these products.  CTP's actions have significant public health and consumer protection impact and are among the most important issues faced by the Agency in its long and distinguished history. The Center for Tobacco Products (CTP) is responsible for implementing the Family Smoking Prevention and Tobacco Control Act. This law gives FDA authority over tobacco products by adding a new chapter to the Food, Drug, and Cosmetic Act. The Tobacco Control Act gives FDA the authority to regulate tobacco products and manufacturers based on the best available science and CTP is responsible for both assessing and fostering that science-base. CTP's actions have significant public health and consumer protection impact and are among the most important issues faced by the Agency in its long and distinguished history.

This Direct Hire position is located in the Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP), Office of Compliance and Enforcement (OCE), located in Silver Spring, MD and Office of Science (OS), located in Beltsville, Maryland.

Responsibilities/Job Duties:
  • Participates in research related to the communication of information about tobacco products such as labeling, advertising, promotion and marketing.
  • Reviews, analyzes, evaluates, consults and measures outcomes of data obtained in studies designed to investigate comprehension, judgment, knowledge and behavior related to tobacco product labeling and/or advertisements.
  • Prepares reports on research results to supervisors, peers, professional societies and industry meetings.
  • Participates in the development of policy associated with providing or presenting information on current trends in social science.
  • Develops and maintains contacts within professional and scientific organizations.

Qualifications:

BASIC REQUIREMENT: This position has a Basic Individual Occupational Requirement (IOR). In order be eligible for the position of Social Scientist, (GS-0101-12/13), you must meet the following requirements...

Have a degree in behavioral or social science; or related disciplines appropriate to the position.
OR
Have a combination of education and experience that provided the applicant with knowledge of one or more of the behavioral or social sciences equivalent to a major in the field.
OR
Have four years of appropriate experience that demonstrated that the applicant has acquired knowledge of one or more of the behavioral or social sciences equivalent to a major in the field.

Minimum Qualifications Requirements:
You must possess one year (52-weeks) of specialized experience, equivalent to at least the next lower grade level in the Federal service. Such experience includes:
GS-12:  You must possess 1 year of specialized experience equivalent at to the GS-11 grade level in the Federal service, analyzing, evaluating, and providing advice to scientific and program specialists on epidemiologic issues; reviewing, evaluating, and synthesizing epidemiologic evidence; and making presentations and responding to inquiries.

GS-13: You must possess 1 year of specialized experience equivalent to the GS-12 grade level in the Federal service, analyzing, evaluating and advising scientific and program specialists on epidemiologic issues; critically reviewing, evaluating, and synthesizing epidemiologic evidence; collecting, analyzing and interpreting technical scientific data as part of epidemiologic studies; and making presentations, responding to inquiries and writing reports.

Specialized Experience Requirements:
In addition to meeting the basic qualifications for the Social Scientist, GS-0101-12 position, you must also meet the following:

Have one year of specialized experience, equivalent to the GS-11 grade level in the Federal service, to include experience in assisting in designing and developing research protocols and conducting research on consumer perceptions, intention and/or use of products that could be applied to tobacco or other regulated products. Volunteer experience can also be used as qualifying experience.

In addition to meeting the basic qualifications for the Social Scientist, GS-0101-13 position, you must also meet the following:

Have one year of specialized experience, equivalent to the GS-11 grade level in the Federal service, to include experience in designing and developing research protocols and conducting research on consumer perceptions, intention and/or use of products that could be applied to tobacco or other regulated products. Volunteer experience can also be used as qualifying experience.

If you are applying based on some other qualifying eligibility (i.e. you are not applying as a current Federal employee), you must meet the specific requirements of the eligibility you are claiming and must have sufficient past experience to demonstrate that you are minimally qualified for this position. Volunteer experience can be used as qualifying experience. See Unique Hiring Paths on USAJOBS for more information about various ways you may be eligible to apply!

Research...

Training...

Pre-Application Webinar for the Basic Research in Cancer Health Disparities PARs


Please register for the Wednesday, April 29, 2020 Webinar!


The NCI will host a pre-application webinar for investigators interested in applying for the “Basic Research in Cancer Health Disparities” funding opportunities. This webinar will provide an overview and technical assistance information relevant to both the R21 and R01 opportunities. Please refer to the fact sheet or more details on these funding announcements and see below for registration information.


Title:             Basic Research in Cancer Health Disparities (R01 and R21) Pre-Application Webinar

Date:             Wednesday, April 29, 2020

Time:             3:00 pm – 4:00 pm ET

Access:          Please register to attend 


Additional Information:

PAR-18-654: Basic Research in Cancer Health Disparities (R01)
PAR-18-655: Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21)

Before applying, applicants are encouraged to read the full funding opportunity announcements and to contact the Scientific/Research Contacts listed below:

Tiffany Wallace, PhD
Center to Reduce Cancer Health Disparities (CRCHD)
National Cancer Institute
240-276-5114
Tiffany.Wallace@nih.gov

SciTS 2020 | The International Science of Team Science Conference Durham, North Carolina, USA | June 1-4, 2020

As the leading international conference for the Science of Team Science, SciTS 2020 will focus on highlighting and pursuing excellence in studying, doing, and teaching team science. Please register here

Funding...

Upcoming Funding Opportunities:

 

NCI Kirschstein-NRSA Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (F31) | Applications are due April 8, Aug. 8, and Dec. 8, 2019 | PA-19-196 


Diversity Research Supplements (New) | Apply between Feb. 1 – March. 30 and Oct. 1 - Dec. 1, 2019 | PA-18-586


Re-entry supplement FOA (New) | Apply between Feb. 1 – March. 30 and Oct.1 - Dec 1, 2019 | PA-18-592


Please use these updated Diversity Supplements Guidelines and Re-Entry Supplements Guidelines along with DS fact sheet to prepare your application.


NCI Mentored Research Scientist Development Award to Promote Diversity (K01) | Applications are due Feb.12, June 12, and Oct. 12, 2019 | PAR-18-364 | PAR-18-365


NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) | Applications are due Feb.12, June 12, and Oct. 12, 2019 | PAR-18-337 | PAR-18-336


NCI Transition Career Development Award to Promote Diversity (K22) | Applications are due Feb.12, June 12, and Oct. 12, 2019 | PAR-18-366 | PAR-18-367


Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) | Applications are due June 19 and Nov. 19, 2019 | PAR-18-655


Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) | Application are due June 19 and Nov.19, 2018 | PAR-18-731


Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | Applications are due June 19 and Nov. 19, 2019 | PAR-18-654


National Cancer Institute Youth Enjoy Science Research Education Program (R25) | Application are due September 25, 2019 | PAR-17-059

 

Other Non-CURE Funding Opportunities 


Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01/R21 Clinical Trial Optional) | Applications are due June 5 and Oct 5, 2019 | PA-18-738 | PA-18-739


*NEW* Co-infection and Cancer (R01/R21 Clinical Trial Not Allowed) | Applications are due March 6, 2020 | PAR-20-062 | PAR-20-061

The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection. 


*NEW* Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01/R21 Clinical Trials Not Allowed) | Applications due April 1, 2020 | PAR-20-088 | PAR-20-081

The purpose of the initiative is to support multidisciplinary exploratory or developmental research to understand the underlying etiologic factors and mechanisms that contribute to population-level disparities in chronic liver diseases and liver cancer in the U.S.


*NEW* Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01/R21 Clinical Trial Optional) | Applications due April 30, 2020 | RFA-CA-20-004 | RFA-CA-20-005

The current issuance of the PQ Initiative includes an updated set of 9 PQs. Each research project proposed in response to this FOA must be focused on addressing the research problems defined by a specific PQ selected from the list. Projects proposed to address PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged if they serve the scientific focus of the selected PQ.


*NEW* Alzheimer’s-focused Administrative Supplements for NIH/NCI Grants that are not focused on Alzheimer’s Disease (NOT-CA-20-019 and related announcements NOT-AG-20-008 and PA-18-591): Applications due March 6, 2020

Parent grant program directors need to be involved in the process with the PIs applying to this supplement.  Grantees cannot have large carryovers and must have one year or more left on their grants.  Administrative supplements are due March 6 and are one-year supplements.


Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) | Applications due date: September 10, 2019 | PA-18-842

*NEW*Administrative Supplements to Support Cancer Disparity Collaborative Research Pre-application 

Due dates: February 10, 2020 and September 10, 2020 Description: If you hold an active NCI-funded R01 (with at least 2 years of support remaining) and are interested in expanding your research to incorporate a cancer disparities research project, please consider submitting a proposal under FOA PA-18-842: Administrative Supplements to Support Cancer Disparity Collaborative Research. Please note that for this FOA, collaborative teams are required between a non-cancer disparities investigator (PI of the R01) and a collaborator who has minority health research or cancer disparities research expertise.


*NEW*The Sexual & Gender Minority Research Office (SGMRO) is pleased to announce the publication of a Notice of Special Interest (NOSI) regarding Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (NOT-OD-20-032). 

Purpose: This Notice of Special Interest (NOSI) announces the availability of administrative supplements to provide funding for the expansion of existing research projects to incorporate sexual and gender minority (SGM) populations, which include, but are not limited to, those populations described in Notice NOT-OD-19-139. Basic, social, behavioral, clinical, translational, and health services research relevant to the missions of the sponsoring NIH Institutes or Centers (ICs) may be proposed in response to this solicitation. Potential applicants are also encouraged to review the FY 2017 Portfolio Analysis of NIH-funded SGM research to identify potential research gaps that may be relevant to this NOSI.

Application Due Dates are January 31, 2020 for FY 2020, January 25, 2021 for FY 2021, by 5:00 PM local time of applicant organization.


NCI Community Oncology Research Program (NCORP) | Research Bases | Community Sites | Minority/Underserved Community Sites Cooperative Agreement | Application Deadline is August 31, 2019 | RFA-CA-18-015 | RFA-CA-18-016 | RFA-CA-18-017


Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | Application due date November 7, 2019 | PAR-18-869


National Cancer Institute’s Healthcare Delivery Research Program (HDRP) supports several current funding opportunities listed down below:


Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01/R21 Clinical Trial Optional) | PA-18-005 | PA-18-015


Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01/R21 Clinical Trial Optional) | PA-18-004 | PA-18-014


Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) | PA-17-495


Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01/R21 Clinical Trial Optional) | PAR-18-246 | PAR-18-247


Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01/R21/R03 Clinical Trial Optional) | PAR-18-008 | PAR-18-019 | PAR-16-337


Using Information Technology to Support Systematic Screening and Treatment of Depression in
Oncology Practices (R01 Clinical Trial Optional) | PAR-18-493 | PAR-18-492


Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21/R01 Clinical Trial Not Allowed) | Applications are due March 4, 2019, March 4, 2020, March 4, 2021| PAR-19-019 | PAR-19-018

The purpose of this initiative is to promote multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.


Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01 Clinical Trial Not Allowed) | Applications are due December 4, 2018 |PAR-17-484

The purpose of this initiative is to support collaborative research between Tribal Epidemiology Centers and extramural investigators on topics related to minority health and health disparities in American Indian / Alaska Native (AI/AN) populations.


Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) | The FOA will open for applications on January 5, 2019 and first standard due date is February 5, 2019 | PA-18-932

This FOA invites applications that seek to understand strategies to reduce disparities by increasing the uptake of evidence-based screenings across the adult lifespan. Research supported by this initiative should enhance the screening process related to use (1) in diverse populations, (2) in diverse clinical and community settings, and/or (3) with traditional, nontraditional, and/or allied health care providers.


NIH: Small Business Innovations for Health Disparities | Letters of Intent March 1 | Deadline for application is April 1 | RFA-MD-19-001


Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20, Clinical Trials Optional) | Application are due June 19, 2019, October 18, 2019, June 19, 2020, and October 18, 2020 | RFA-CA-19-034

Purpose: The goals for this FOA include developing translational research programs focused on investigating cancer disparities. The P20 grants will support feasibility and planning activities to build cancer disparities research programs, with the expectation that the research programs will become competitive for a full P50 SPORE. Reissue of RFA-CA-17-034 (resubmissions will be accepted). New restrictions: Due to a focus on understudied areas of cancer disparities, applications proposing prostate and breast cancer projects are not responsive for this issuance.

A pre-application webinar is planned for late April.  A Notice will be published on the RFA with the date and a link to registration.

 

New Funding Opportunities


*NEW* Notice of Special Interest (NOSI): NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment; NOT-CA-19-059

Contact: Sallie Weaver Application Due Date: This NOSI applies to due dates on or after September 25, 2019 through January 8, 2022.  Applications related to this NOSI may be submitted using the following funding opportunity announcements or future reissuances: PAR-18-869, PAR-18-559, PA-19-056, PAR-18-290 An informational webinar is being planned.  Please check our website for updates.


*NEW* Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization; PAR-19-352 (R01), PAR-19-355 (R21)

Contact: Michelle Mollica Next Submission Date: October 17, 2019 (R01); October 16, 2019 (R21) Expiration Date: September 8, 2022

*NEW* Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake; PAR-19-360 (R01), PAR-19-358 (R21), PAR-19-359 (R03)

Contact: Sarah Kobrin Next Submission Date: October 17, 2019 (R01); October 16, 2019 (R21 and R03) Expiration Date: September 8, 2022 (R01 and R21); July 17, 2022 (R03)


Software for Patient Navigation Through the Cancer Care Continuum (Topic 406): PHS2020-1 SBIR Contract Solicitation

Contact: Gurvaneet Randhawa Application Due Date: October 23, 2019

Dissemination and Implementation Research in Health, PAR-19-274 (R01), PAR-19-275 (R21), PAR-19-276 (R03)

Contact: Gila Neta, Wynne E. Norton, and David Chambers (from the DCCPS Implementation Science Team) Next Submission Date: October 5, 2019 (R01), October 16, 2019 (R21 and R03) Expiration Date: May 8, 2022


Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R01/R21/R03) The purpose of this Funding Opportunity Announcement (FOA) is to support innovative approaches to identifying, developing, testing, evaluating and/or refining strategies to disseminate and implement evidence-based practices

New applications are due by October 5, 2019 by 5:00 PM local time of applicant organization. For more on standard applications deadlines visit: https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm Program staff are available to answer questions. Contact information and funding resources are available online.


Funding Opportunity Announcement Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01/R03/R21) This FOA encourages research on how the health care delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and health care delivery.

Application Due Dates:

Sample Grant Applications The National Cancer Institute (NCI) frequently receives questions from investigators for examples of successfully funded grant applications. Several investigators and their organizations agreed to let the Division of Cancer Control & Population Sciences (DCCPS) programs post excerpts of their grant applications online.

 

Other Federal Grants


*NEW* CMS Minority Research Grant Program | June 2, 2020 | CMS-1W1-20-001

The Office of Minority Health at the Centers for Medicare and Medicaid Services (CMS) will make two awards of $250,000 each to support research at minority-serving institutions.  Eligible applicants are public and private institutions of higher education that can enhance CMS capacity for reducing health disparities in minority populations.

 

Looking for additional funding opportunities? A full list of CRCHD funding opportunities as well as select NIH opportunities is available online.

To connect with GMaP Region 3...

Visit GMaP online at gmap-region3.com

Are you interested in becoming a Region 3 GMaP member? Contact Director Miria Kano by email, or phone at 505-925-1115.
Share
Tweet
Forward






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GMaP · 1201 Camino de Salud NE · Albuquerque, NM 87131 · USA